Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

CymaBay Therapeutics (United States) | Researchclopedia

Back to institutions

CymaBay Therapeutics (United States)

Newarkcompany

48

Works

4,019

Citations

35

h-index

Top Research Topics

Liver Diseases and Immunity Liver Disease Diagnosis and Treatment Drug Transport and Resistance Mechanisms

Top Researchers

Dong Chen Dalian University of Technology

909 works27,752 citationsh-index: 77

Recent Research

Review Article: Targeting Peroxisome Proliferator‐Activated Receptors in Primary Biliary Cholangitis

Jörn M. Schattenberg,Jesús M. Bañales,et al.

20260 citations

Pediatric Hepatobiliary Diseases and Treatments

Gallbladder and Bile Duct Disorders

Peroxisome Proliferator-Activated Receptors

Pancreatitis Pathology and Treatment

Gout, Hyperuricemia, Uric Acid

Cancer Research and Treatments

Alkaline Phosphatase Research Studies

Trypanosoma species research and implications

Lysosomal Storage Disorders Research

Ke Yang Guangzhou University of Chinese Medicine

541 works11,436 citationsh-index: 56

Robert L. Martin Murray State University

253 works5,139 citationsh-index: 38

Yuntao Song Ministry of Education

277 works4,526 citationsh-index: 29

Daria B. Crittenden Gilead Sciences (Canada)

92 works4,383 citationsh-index: 23

Yun‐Jung Choi Jeonju National University of Education

122 works4,004 citationsh-index: 37

Challenges facing the PBC community: insights from the PBC International Summit

Robert Mitchell-Thain,Alexander Artyomenko,et al.

20250 citations

EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND COMPENSATED CIRRHOSIS IN THE PHASE 3 PLACEBO-CONTROLLED RESPONSE TRIAL

Alejandra Villamil,Ziad Younes,et al.

20250 citations

Alkaline phosphatase changes with seladelpar across subgroups of primary biliary cholangitis patients in the response trial

Kris V. Kowdley,Kidist Yimam,et al.

20250 citations

Long-term efficacy and safety of open-label seladelpar treatment in patients with primary biliary cholangitis: pooled interim results for up to 3 years from the ASSURE study

E.J. Lawitz,P.J. Trivedi,et al.

20250 citations

Assessment of <scp>PBC</scp> Pruritus From the <scp>ITCH</scp> ‐E Study: Quality of Life, Productivity, and Treatment Experiences

Cynthia Levy,Zobair M. Younossi,et al.

20253 citations